US Bancorp DE Decreases Holdings in The Clorox Company (NYSE:CLX)

US Bancorp DE lowered its stake in shares of The Clorox Company (NYSE:CLX) by 3.8% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 129,134 shares of the company’s stock after selling 5,042 shares during the period. US Bancorp DE owned about 0.10% of Clorox worth $21,037,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently modified their holdings of CLX. Innealta Capital LLC acquired a new stake in shares of Clorox in the second quarter worth approximately $30,000. Trifecta Capital Advisors LLC grew its holdings in shares of Clorox by 139.8% during the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after buying an additional 130 shares in the last quarter. First Foundation Advisors acquired a new stake in shares of Clorox in the first quarter valued at about $31,000. Family Firm Inc. purchased a new position in shares of Clorox in the second quarter worth about $31,000. Finally, Quarry LP grew its stake in Clorox by 99.1% during the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after acquiring an additional 114 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Analyst Ratings Changes

CLX has been the subject of a number of analyst reports. Barclays upped their price target on Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a research report on Friday. Deutsche Bank Aktiengesellschaft lifted their price target on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and upped their price objective for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. JPMorgan Chase & Co. lifted their target price on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research note on Friday, October 11th. Finally, TD Cowen began coverage on shares of Clorox in a research note on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 price target for the company. Six investment analysts have rated the stock with a sell rating, nine have issued a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $150.29.

Clorox Stock Up 2.9 %

Shares of CLX opened at $163.12 on Friday. The company’s 50-day simple moving average is $161.48 and its 200-day simple moving average is $146.14. The company has a debt-to-equity ratio of 5.04, a quick ratio of 0.63 and a current ratio of 1.03. The Clorox Company has a 1 year low of $121.76 and a 1 year high of $169.09. The stock has a market capitalization of $20.20 billion, a PE ratio of 56.84, a P/E/G ratio of 3.12 and a beta of 0.41.

Clorox (NYSE:CLX) last released its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. The company had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 292.08%. The firm’s quarterly revenue was up 27.0% on a year-over-year basis. During the same period in the prior year, the business earned $0.49 EPS. Analysts forecast that The Clorox Company will post 6.64 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be paid a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a yield of 2.99%. Clorox’s payout ratio is 170.04%.

Insider Buying and Selling at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the transaction, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.57% of the stock is owned by corporate insiders.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.